New disease models for investigating SynGAP1-related disorder (SRD) caused by a common heterozygous nonsense SYNGAP1 mutation

Mutations in the SYNGAP1 gene cause SynGAP1-related disorder (SRD), a severe neurodevelopmental disorder marked by intellectual disability, epilepsy, ataxia, autism spectrum disorder, and global developmental delay. Studies in mouse models of SRD show that restoration of SynGAP1 expression in adult animals improves memory and seizure threshold, highlighting the disorders potential for successful therapeutic intervention over the entire lifetime. We established an integrated disease-modelling pipeline centered on the recurrent SYNGAP1 c.427C>T, p.(Arg143Ter), nonsense mutation, integrating neuronal and organoid models from patient-derived human induced pluripotent stem cells (hiPSCs) and a humanized knock-in mouse line to investigate mutation-specific disease phenotype across complementary experimental systems. We demonstrate that the c.427C>T mutation leads to a reduction of SynGAP1 protein levels and a corresponding dysregulation of Ras/ERK signaling in human forebrain organoids as well as in the mouse model system. In vivo, mice harboring the c.427C>T mutation show a hyperactivity phenotype that corresponds well to phenotypic features seen in patients such as absence of fear, hyperactive behavior and a strong urge to investigate the immediate surroundings. Taken together, our molecular and behavioral data in the humanized mouse are in line with studies on conventional heterozygous SynGAP1 knockout models, underscoring the relevance of these new disease models for further investigations into disease pathology. Moreover, with the three models described here, we present a translational platform that enables the development and evaluation of gene therapies that target disease-causing single nucleotide variations in the SYNGAP1 coding sequence.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-13
DOI
https://doi.org/10.64898/2026.11.11.765833
Primary Topic
Genetics and Neurodevelopmental Disorders
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

New disease models for investigating SynGAP1-related disorder (SRD) caused by a common heterozygous nonsense SYNGAP1 mutation

Judith von Sivers, Hanna Hörnberg, Sarah A. Shoichet, Markus Schuelke et al.
3 links
bioRxiv (Cold Spring Harbor Laboratory)
Genetics and Neurodevelopmental Disorders
preprint

New disease models for investigating SynGAP1-related disorder (SRD) caused by a common heterozygous nonsense SYNGAP1 mutation

Judith von Sivers, Hanna Hörnberg, Sarah A. Shoichet, Markus Schuelke, Nils Rademacher, Agnieszka Rybak‐Wolf, Ralf Kühn, Dietmar Schmitz, Taanisha Gupta, Clara Unger, Daniel Bauersachs, Rosalba Olga Proce, Ivanna Kupryianchyk-Schultz
preprint en

Abstract

Mutations in the SYNGAP1 gene cause SynGAP1-related disorder (SRD), a severe neurodevelopmental disorder marked by intellectual disability, epilepsy, ataxia, autism spectrum disorder, and global developmental delay. Studies in mouse models of SRD show that restoration of SynGAP1 expression in adult animals improves memory and seizure threshold, highlighting the disorders potential for successful therapeutic intervention over the entire lifetime. We established an integrated disease-modelling pipeline centered on the recurrent SYNGAP1 c.427C>T, p.(Arg143Ter), nonsense mutation, integrating neuronal and organoid models from patient-derived human induced pluripotent stem cells (hiPSCs) and a humanized knock-in mouse line to investigate mutation-specific disease phenotype across complementary experimental systems. We demonstrate that the c.427C>T mutation leads to a reduction of SynGAP1 protein levels and a corresponding dysregulation of Ras/ERK signaling in human forebrain organoids as well as in the mouse model system. In vivo, mice harboring the c.427C>T mutation show a hyperactivity phenotype that corresponds well to phenotypic features seen in patients such as absence of fear, hyperactive behavior and a strong urge to investigate the immediate surroundings. Taken together, our molecular and behavioral data in the humanized mouse are in line with studies on conventional heterozygous SynGAP1 knockout models, underscoring the relevance of these new disease models for further investigations into disease pathology. Moreover, with the three models described here, we present a translational platform that enables the development and evaluation of gene therapies that target disease-causing single nucleotide variations in the SYNGAP1 coding sequence.

bioRxiv (Cold Spring Harbor Laboratory)
Max Delbrück Center (DE), Charité - Universitätsmedizin Berlin (DE)
Deutsche Forschungsgemeinschaft, Einstein Stiftung Berlin
Good health and well-being
Genetics and Neurodevelopmental Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon